Placebo News and Research

RSS

Over-the-counter antioxidant may promote reductions in alcohol use in marijuana-dependent teens

An over-the-counter antioxidant known as N-acetylcysteine (NAC) is showing early promise at promoting abstinence from or reduced use of alcohol in marijuana-dependent adolescents, report researchers at the Medical University of South Carolina (MUSC) in the December 2016 Addictive Behaviors.

15 Dec 2016

FDA approves new treatment option for patients dealing with mild to moderate eczema

The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.

14 Dec 2016

Innovation in stroke aftercare across Europe: an interview with Professor Urs Fischer

Stroke is the epidemic disease of the twenty-first century and the second most frequent cause of death in 2011, accounting for 11% of all deaths worldwide. Stroke is also the second most important cause of permanent disability and...

13 Dec 2016

Symptoms from other causes may be mistaken for side effects of breast cancer drug

Women taking tamoxifen to prevent breast cancer were less likely to continue taking the drug if they suffered nausea and vomiting, according to new data presented at the San Antonio Breast Cancer Symposium today (Friday).

9 Dec 2016

Oxytocin levels affect synchronization in leader/follower relationship

When standing in a crowd at a concert, clapping hands along with the music on stage, it may be that people with higher levels of oxytocin are better synchronised with the beat of the music than those with lower levels of oxytocin.

9 Dec 2016

Depression drug can alleviate joint pain in postmenopausal women treated for breast cancer

A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.

9 Dec 2016

Investigational diabetes drug that impedes Parkinson's progression getting ready for human trials

A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world's first treatment to impede the progression of Parkinson's disease following publication of research findings today in the journal Science Translational Medicine.

7 Dec 2016

Preventing C. difficile infections could save thousands of lives and millions of health care dollars

The constant fear of having an embarrassing bathroom accident paralyzed Judy Post. Mental, physical and emotional stress consumed her. She wondered if her life would ever return to normal.

7 Dec 2016

Brazilian researchers propose new way for treating thalassemia major

Iron accumulation in myocardial cells, potentially resulting in heart failure or fatal arrhythmia, is one of the complications most feared by patients with thalassemia major, a hereditary disease also known as Mediterranean anemia.

7 Dec 2016

Researchers to study effect of watermelon juice in reducing heart disease

University of Alabama researchers soon will launch a study that looks at watermelon juice as a way to reduce heart disease.

6 Dec 2016

Auditory deficits in people with schizophrenia linked to dysfunctional brain receptors

The inability to hear subtle changes in pitch, a common and debilitating problem for people with schizophrenia, is due to dysfunctional N-methyl-D-aspartate (NMDA) brain receptors, according to a study by Columbia University Medical Center researchers.

2 Dec 2016

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.

2 Dec 2016

Alpha blockers benefit patients with larger kidney stones

Nearly one in 11 Americans will have a kidney stone in their lifetime, causing pain, sometimes missed work and, often, a lot of money.

2 Dec 2016

Hallucinogenic drug offers relief for people with cancer-related anxiety or depression

In a small double-blind study, Johns Hopkins researchers report that a substantial majority of people suffering cancer-related anxiety or depression found considerable relief for up to six months from a single large dose of psilocybin -- the active compound in hallucinogenic "magic mushrooms."

2 Dec 2016

Placebo News and Research

Over-the-counter antioxidant may promote reductions in alcohol use in marijuana-dependent teens

FDA approves new treatment option for patients dealing with mild to moderate eczema

Innovation in stroke aftercare across Europe: an interview with Professor Urs Fischer

Symptoms from other causes may be mistaken for side effects of breast cancer drug

Oxytocin levels affect synchronization in leader/follower relationship

Depression drug can alleviate joint pain in postmenopausal women treated for breast cancer

Investigational diabetes drug that impedes Parkinson's progression getting ready for human trials

Preventing C. difficile infections could save thousands of lives and millions of health care dollars

Brazilian researchers propose new way for treating thalassemia major

Researchers to study effect of watermelon juice in reducing heart disease

Auditory deficits in people with schizophrenia linked to dysfunctional brain receptors

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

Alpha blockers benefit patients with larger kidney stones

Hallucinogenic drug offers relief for people with cancer-related anxiety or depression

Drexel researchers one step closer to offering new treatment for chronic wounds

Study shows heart medications prevent cardiovascular damage during breast cancer treatment

NIH-supported first HIV vaccine efficacy study begins in South Africa

Pharmacotherapy combined with rehabilitation program offers hope for traumatic brain injury patients

Clinically-proven pharmacy product effective against causes of Traveller's Diarrhoea

Dietary supplement extracted from Amaranthus can increase plasma nitrate, study shows

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News